OpenAI backs Coherence Neuro's $45M bet on cancer-detecting brain implants
What's the deal? OpenAI's venture arm has backed Coherence Neuro, a startup developing brain implants that aim to detect — and potentially treat — brain tumors. The investment came as part of a $45 million seed round, which Founders Fund also joined.
What's the endgame? Coherence wants its implants to sense brain-tumor signals and, eventually, treat them with electrical stimulation. That is a far less established use than most brain-computer interfaces, which focus on restoring communication or movement.
Why now? The round lands amid heavy investment in brain-computer interfaces. Neuralink has raised $650 million, and Precision Neuroscience recently announced a $250 million round.
What could go wrong? Coherence's human work so far amounts to brief testing during surgery in three patients. Long-term monitoring and clinical benefit remain unproven.
The signal: The deal is one of a growing wave of bets AI companies are making on brain data. But it reflects a high-profile wager on an early oncology hypothesis — not evidence that a cancer-detecting implant is near clinical use.
Read more: technewstube.com
Image credit: Generated with Gemini
